Trademark: 88873547
Status Date
Monday, December 18, 2023
Filing Date
Wednesday, April 15, 2020
Published for Opposition
Tuesday, September 21, 2021
Abandoned Date
Monday, December 18, 2023
40 Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies by pharmaceutical compounders; custom manufacturing for others, namely, manufacturing of pharmaceutical and veterinary preparations for health care, for the treatment of humans and animals suffering from diseases treated by cell therapy or regenerative medicine products by pharmaceutical compounders, namely, medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies
9 Downloadable computer software for accessing a database featuring information in the medical field, namely, stem cell therapy related information; Downloadable software applications for telephones, tablets, computers allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers allowing the access to information, monitoring and managing systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; downloadable electronic publications in the nature of electronic questionnaires in the field of advanced therapy and cell therapy medications; none of the foregoing in the field of pharmaceutical and veterinary products
37 Installation, repair and maintenance services of medical and scientific apparatus and instruments for the manufacturing of autologous and allogeneic biological cell therapies
1 Chemical, biological and biochemical products for industrial and scientific purposes, other than for medical purposes, namely, biological tissue cultures for industrial and scientific purposes and not for medical or veterinary purposes; reagents for scientific and research use
44 Stem cell therapy services; autologous and allogeneic cell therapy services in the nature of medical services, namely, diagnostic and therapeutic services, namely, genetic testing of humans for health assessment, diagnostic or treatment and medical purposes; autologous and allogeneic cell therapy services in the nature of medical services for the treatment of hematological malignancies; Medical and health care, namely, administration of cell therapy services for the treatment of hematological malignancies
10 Medical equipment for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system for use in the creation of biological cell therapies for medical purposes; disposable single-use containers for solutions used for the manufacturing of autologous and allogeneic biological cell therapies, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form for medical use
42 Research and development services in the field of cell therapies; Scientific research in human and animal cell therapy; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Medical and scientific research in the field of cell therapy; technical assessments relating to design, namely, technical design consultation in the field of manufacture of advanced therapy and cell therapy medications; Technical research in the field of manufacture of advanced therapy and cell therapy medications; Software as a service (SaaS) services featuring software for assisting in the diagnosis of medical conditions in relation to advanced therapy and cell therapy medications; Cloud computing featuring software for use in assisting in the diagnosis of medical conditions; Providing search engines for the internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, creating an online virtual community for registered users to organize groups and events, participate in discussion, and network with social and business communities in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, hosting online web facilities for others for organizing colloquiums, events and interactive discussions, via communication networks in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Hosting digital content for users account in the Internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; designing websites for others, namely, designing online forums in the field of manufacture of advanced therapy and cell
Dec 18, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 18, 2023
Abandonment - No Use Statement Filed
May 11, 2023
Notice Of Approval Of Extension Request E-Mailed
May 9, 2023
Sou Extension 3 Granted
May 9, 2023
Sou Extension 3 Filed
May 9, 2023
Sou Teas Extension Received
Nov 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2022
Sou Extension 2 Granted
Nov 7, 2022
Sou Extension 2 Filed
Nov 7, 2022
Sou Teas Extension Received
Jul 27, 2022
Teas Change Of Correspondence Received
Jul 27, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 27, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 3, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2022
Sou Extension 1 Granted
Apr 29, 2022
Sou Extension 1 Filed
Apr 29, 2022
Sou Teas Extension Received
Nov 16, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 29, 2021
Assigned To Examiner
Sep 21, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 21, 2021
Published For Opposition
Sep 1, 2021
Notification Of Notice Of Publication E-Mailed
Aug 13, 2021
Approved For Pub - Principal Register
Jul 30, 2021
Teas/Email Correspondence Entered
Jul 30, 2021
Correspondence Received In Law Office
Jul 30, 2021
Teas Request For Reconsideration Received
Feb 2, 2021
Notification Of Final Refusal Emailed
Feb 2, 2021
Final Refusal E-Mailed
Feb 2, 2021
Final Refusal Written
Jan 11, 2021
Teas/Email Correspondence Entered
Jan 11, 2021
Correspondence Received In Law Office
Jan 11, 2021
Teas Response To Office Action Received
Jul 9, 2020
Notification Of Non-Final Action E-Mailed
Jul 9, 2020
Non-Final Action E-Mailed
Jul 9, 2020
Non-Final Action Written
Jul 6, 2020
Assigned To Examiner
Apr 23, 2020
New Application Office Supplied Data Entered
Apr 18, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
